Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and parthenolide

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with parthenolide in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(parthenolide)
Trials
(parthenolide)
Recent Studies (post-2010) (parthenolide)
9,1561875526125323

Protein Interaction Comparison

ProteinTaxonomy1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50)parthenolide (IC50)
Nitric oxide synthase, inducibleMus musculus (house mouse)4.525
Prostaglandin G/H synthase 2Homo sapiens (human)0.8

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, JH; Heon Seo, K; Im, SY; Jun Park, S; Kim, HA; Kim, KJ; Ko, HM; Lee, HK1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and parthenolide

ArticleYear
Platelet-activating factor induces up-regulation of antiapoptotic factors in a melanoma cell line through nuclear factor-kappaB activation.
    Cancer research, 2006, May-01, Volume: 66, Issue:9

    Topics: Animals; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; bcl-X Protein; Caspase Inhibitors; Caspases; Cell Line, Tumor; Drug Interactions; Etoposide; Female; Melanoma, Experimental; Mice; Mice, Inbred C57BL; NF-kappa B; Platelet Activating Factor; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Sesquiterpenes; Up-Regulation

2006